Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.
Cecile Riviere-CazauxJean M LaceyLucas P CarlstromWilliam J LaxenAmanda Munoz-CasabellaMatthew D HoplinSamar IkramAbdullah Bin ZubairKatherine M AndersenArthur E WarringtonPaul A DeckerTimothy J KaufmannJian L CampianJeanette E Eckel-PassowSani H KizilbashSilvia TortorelliTerry C BurnsPublished in: Neuro-oncology advances (2023)